openPR Logo
Press release

Sturge-Weber Syndrome Market to Expand Significantly by 2032, States DelveInsight Report | Anne Comi, MD, Qlaris Bio, Inc

07-17-2025 10:36 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Sturge-Weber Syndrome Market to Expand Significantly by 2032,

DelveInsight's "Sturge-Weber Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Sturge-Weber Syndrome, historical and forecasted epidemiology as well as the Sturge-Weber Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Sturge-Weber Syndrome, offering comprehensive insights into the Sturge-Weber Syndrome revenue trends, prevalence, and treatment landscape. The report delves into key Sturge-Weber Syndrome statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Sturge-Weber Syndrome therapies. Additionally, we cover the landscape of Sturge-Weber Syndrome clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Sturge-Weber Syndrome treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Sturge-Weber Syndrome space.

To Know in detail about the Sturge-Weber Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Sturge-Weber Syndrome Market Forecast
https://www.delveinsight.com/sample-request/sturge-weber-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Sturge-Weber Syndrome Market Report:
• The Sturge-Weber Syndrome market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Key Sturge-Weber Syndrome Companies: Anne Comi, MD, Qlaris Bio, Inc., and others
• Key Sturge-Weber Syndrome Therapies: QLS-101, and others
• The Sturge-Weber Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Sturge-Weber Syndrome pipeline products will significantly revolutionize the Sturge-Weber Syndrome market dynamics.
• Rare Congenital Disorder Occurs in approximately 1 in 20,000 to 50,000 live births worldwide.
• Sturge-weber Syndrome affects males and females equally with no known ethnic or racial predisposition.
• Port-Wine Stain Prevalence, About 3 in 1,000 newborns have a port-wine stain, but only a small fraction develop Sturge-Weber Syndrome.
• Neurological Manifestations 80-90% of patients experience seizures, often beginning in infancy.
• Unilateral vs. Bilateral Brain Involvement, Most cases have unilateral brain involvement, but bilateral cases (20-30%) tend to have more severe symptoms.

Sturge-Weber Syndrome Overview
Sturge-Weber Syndrome is a rare neurological disorder present at birth, characterized by a facial port-wine birthmark, abnormal blood vessels in the brain, and sometimes eye abnormalities like glaucoma. It results from a genetic mutation (not inherited) that affects blood vessel development. The condition can cause seizures, developmental delays, weakness on one side of the body (hemiparesis), and vision problems. The severity and symptoms vary by individual. While there is no cure, treatment focuses on managing seizures, eye issues, and developmental support to improve quality of life.

Get a Free sample for the Sturge-Weber Syndrome Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/sturge-weber-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Sturge-Weber Syndrome Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Sturge-Weber Syndrome Epidemiology Segmentation:
The Sturge-Weber Syndrome market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Sturge-Weber Syndrome
• Prevalent Cases of Sturge-Weber Syndrome by severity
• Gender-specific Prevalence of Sturge-Weber Syndrome
• Diagnosed Cases of Episodic and Chronic Sturge-Weber Syndrome

Download the report to understand which factors are driving Sturge-Weber Syndrome epidemiology trends @ Sturge-Weber Syndrome Epidemiology Forecast
https://www.delveinsight.com/sample-request/sturge-weber-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Sturge-Weber Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Sturge-Weber Syndrome market or expected to get launched during the study period. The analysis covers Sturge-Weber Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Sturge-Weber Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Sturge-Weber Syndrome Therapies and Key Companies
• QLS-101: Qlaris Bio, Inc.

Discover more about therapies set to grab major Sturge-Weber Syndrome market share @ Sturge-Weber Syndrome Treatment Landscape
https://www.delveinsight.com/sample-request/sturge-weber-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Sturge-Weber Syndrome Market Drivers
• Advancements in Genetic Research
• Increased Awareness & Early Diagnosis
• Development of Targeted Therapies
• Growing Investments in Rare Disease Research
• Technological Advancements in Imaging
• Rising Government & Non-Profit Support

Sturge-Weber Syndrome Market Barriers
• Lack of Approved Targeted Therapies
• High Treatment Costs
• Limited Awareness in Underdeveloped Regions
• Complex Disease Management
• Small Patient Population

Scope of the Sturge-Weber Syndrome Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Sturge-Weber Syndrome Companies: Anne Comi, MD, Qlaris Bio, Inc., and others
• Key Sturge-Weber Syndrome Therapies: QLS-101, and others
• Sturge-Weber Syndrome Therapeutic Assessment: Sturge-Weber Syndrome current marketed and Sturge-Weber Syndrome emerging therapies
• Sturge-Weber Syndrome Market Dynamics: Sturge-Weber Syndrome market drivers and Sturge-Weber Syndrome market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Sturge-Weber Syndrome Unmet Needs, KOL's views, Analyst's views, Sturge-Weber Syndrome Market Access and Reimbursement

To know more about Sturge-Weber Syndrome companies working in the treatment market, visit @ Sturge-Weber Syndrome Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/sturge-weber-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Sturge-Weber Syndrome Market Report Introduction
2. Executive Summary for Sturge-Weber Syndrome
3. SWOT analysis of Sturge-Weber Syndrome
4. Sturge-Weber Syndrome Patient Share (%) Overview at a Glance
5. Sturge-Weber Syndrome Market Overview at a Glance
6. Sturge-Weber Syndrome Disease Background and Overview
7. Sturge-Weber Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Sturge-Weber Syndrome
9. Sturge-Weber Syndrome Current Treatment and Medical Practices
10. Sturge-Weber Syndrome Unmet Needs
11. Sturge-Weber Syndrome Emerging Therapies
12. Sturge-Weber Syndrome Market Outlook
13. Country-Wise Sturge-Weber Syndrome Market Analysis (2019-2032)
14. Sturge-Weber Syndrome Market Access and Reimbursement of Therapies
15. Sturge-Weber Syndrome Market Drivers
16. Sturge-Weber Syndrome Market Barriers
17. Sturge-Weber Syndrome Appendix
18. Sturge-Weber Syndrome Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Sturge-Weber Syndrome Pipeline https://www.delveinsight.com/report-store/sturge-weber-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Sturge-Weber Syndrome Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Sturge-Weber Syndrome market. A detailed picture of the Sturge-Weber Syndrome pipeline landscape is provided, which includes the disease overview and Sturge-Weber Syndrome treatment guidelines.

Sturge-Weber Syndrome Epidemiology https://www.delveinsight.com/report-store/sturge-weber-syndrome-sws-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Sturge-Weber Syndrome Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Sturge-Weber Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight:
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Dry Eye Disease Market: https://www.delveinsight.com/report-store/dry-eye-disease-market-insights
• Nonalcoholic Steatohepatitis Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Female Infertility Market: https://www.delveinsight.com/report-store/female-infertility-market
• Gonorrhea Market: https://www.delveinsight.com/report-store/gonorrhea-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Structural Heart Devices Market: https://www.delveinsight.com/report-store/structural-heart-devices-market-market
• Prosthetic Heart Valve Market: https://www.delveinsight.com/report-store/prosthetic-heart-valve-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sturge-Weber Syndrome Market to Expand Significantly by 2032, States DelveInsight Report | Anne Comi, MD, Qlaris Bio, Inc here

News-ID: 4108902 • Views:

More Releases from DelveInsight Business Research

Global Patient Flow Management Solutions Market to was valued USD 1,555.65 million in 2024 growing at a CAGR of 22.08% by 2032, Evaluates DelveInsight
Global Patient Flow Management Solutions Market to was valued USD 1,555.65 milli …
According to DelveInsight's analysis, The growing need for patient flow management solutions is largely fueled by the increasing number of chronic conditions such as diabetes and cardiovascular diseases, which require continuous care and monitoring. The move toward more patient-focused healthcare, along with technological advancements and the introduction of innovative products, is further boosting market expansion. Moreover, government-backed initiatives promoting digital health adoption are playing a key role in supporting the
Global Orphan Drugs Market to reach USD 357.26 billion growing at a CAGR of 6.98% by 2032, Evaluates DelveInsight
Global Orphan Drugs Market to reach USD 357.26 billion growing at a CAGR of 6.98 …
According to DelveInsight's analysis, The orphan drugs market is seeing strong expansion, largely due to the increasing number of rare and genetic diseases worldwide and the significant unmet need for effective treatments. Since many rare conditions still lack approved therapies, the market presents major growth potential. Supportive government regulations-such as incentives, market exclusivity, and faster approval processes-are also encouraging more companies to invest in orphan drug development by lowering financial
Global Antidote Market to reach USD 4,007.09 million growing at a CAGR of 7.13% by 2032, Evaluates DelveInsight
Global Antidote Market to reach USD 4,007.09 million growing at a CAGR of 7.13% …
According to DelveInsight's analysis, The antidote market is expanding rapidly, largely due to the growing cases of poisoning, drug overdoses, and increased incidents of snake and animal bites. This rising demand is supported by greater public health awareness, government programs aimed at overdose prevention and treatment, and continuous advancements in antidote development. Moreover, new product launches and innovations by major industry players addressing toxic exposures are further strengthening market growth.
Global Artificial Intelligence In Drug Discovery Market to grow at a CAGR of 37.67% by 2032, Evaluates DelveInsight
Global Artificial Intelligence In Drug Discovery Market to grow at a CAGR of 37. …
According to DelveInsight's analysis, The AI in drug discovery market is experiencing strong growth due to the increasing global burden of diseases, the benefits AI brings to pharmaceutical development, and rising investments in R&D. Additionally, growing collaborations and strategic partnerships between public and private organizations, both domestically and internationally, are expected to further accelerate market expansion throughout the 2025-2032 forecast period. DelveInsight's "Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and